evonetix

Evonetix places first DNA synthesis development platform at Imperial College London

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialisation 4 October 2023 -- Cambridge, UK -- EVONETIX, the company developing semiconductor scale technology to improve access to gene synthesis, today announced its first placement of a DNA synthesis development platform for evaluation...

Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on its Semiconductor Chip

Cambridge, UK 16th August 2022 - EVONETIX LTD (ëEvonetixí), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetixís DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Companyís...

Evonetix Appoints Colin McCracken as Chief Executive Officer

Cambridge, UK, 13 June 2022: EVONETIX LTD (ëEvonetixí), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colinís appointment will support the next phase of the Companyís development and the commercialisation of its semiconductor-based DNA synthesis platform.

Evonetix Demonstrates Novel Enzymatic DNA Synthesis Method

Cambridge, UK 01 March 2022- EVONETIX LTD (ëEvonetixí), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has achieved enzymatic DNA synthesis capability with its proprietary, thermally controlled synthesis chemistry. The culmination of a three-year development programme, supported by Innovate UK and in collaboration with Durham University, the results demonstrate that...
9a Coldham’s Business Park, Norman Way Cambridge CB1 3LH

+44 1223 930300